
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| VASOPRESSIN | American Regent | N-212593 RX | 2020-08-03 | 2 products, RLD, RS |
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | Baxter | N-217569 RX | 2023-09-29 | 2 products, RLD, RS |
| VASOSTRICT | Endo | N-204485 RX | 2014-04-17 | 4 products, RLD, RS |
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | Long Grove Pharmaceuticals | N-217766 RX | 2024-07-11 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| vasopressin | ANDA | 2025-08-26 |
| vasopressin in 0.9% sodium chloride | New Drug Application | 2025-06-17 |
| vasostrict | New Drug Application | 2023-11-16 |
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Vasopressin, Vasostrict, Par Sterile Products | |||
| 9375478 | 2035-01-30 | U-1857 | |
| 9687526 | 2035-01-30 | U-1857 | |
| 9744209 | 2035-01-30 | U-1857 | |
| 9744239 | 2035-01-30 | U-1857 | |
| 9750785 | 2035-01-30 | DP | |
| 9919026 | 2035-01-30 | DP | |
| 9925233 | 2035-01-30 | U-1857 | |
| 9925234 | 2035-01-30 | U-1857 | |
| 9937223 | 2035-01-30 | U-1857 | |
| 9962422 | 2035-01-30 | U-1857 | |
| 9968649 | 2035-01-30 | U-1857 | |
| 9974827 | 2035-01-30 | U-1857 | |
| 9981006 | 2035-01-30 | U-1857 | |
| 10010575 | 2035-01-30 | U-1857 | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
| Drug common name | Vasopressin |
| INN | vasopressin injection |
| Description | Argipressin is the predominant form of mammalian vasopressin (antidiuretic hormone). It is a nonapeptide containing an arginine at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. It has a role as a cardiovascular drug, a hematologic agent and a mitogen. It is a conjugate base of an argipressin(2+). |
| Classification | Protein |
| Drug class | vasoconstrictors (vasopressin derivatives) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O |
| PDB | — |
| CAS-ID | 113-79-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL373742 |
| ChEBI ID | 34543 |
| PubChem CID | 644077 |
| DrugBank | DB00067 |
| UNII ID | Y87Y826H08 (ChemIDplus, GSRS) |



